The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women

Archives of Internal Medicine

Volumn 154, Issue 12, 1994, Pages 1333-1339

  Psaty, Bruce M ^a,b   Heckbert, Susan R ^b   Atkins, David ^a   Lemaitre, Rozenn ^a,b   Koepsell, Thomas D ^b   Wahl, Patricia W ^b   Siscovick, David S ^a,b   Wagner, Edward H ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY RISK; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; ESTROGEN THERAPY; FEMALE; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; CASE-CONTROL STUDIES; DRUG THERAPY, COMBINATION; ESTROGENS; FEMALE; HUMANS; LOGISTIC MODELS; MEDROXYPROGESTERONE; MYOCARDIAL INFARCTION; POSTMENOPAUSE; RISK FACTORS;

EID: 0028237283     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.154.12.1333     Document Type: Article

References (22)

1. Smith DC, Prentice R, Thompson DJ, Herrmann WL. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med. 1975;293:1164-1167.
2. Hemminki E, Kennedy DL, Baum C, McKinlay SM. Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-1986. Am J Public Health. 1988;78:1478-1481.
3. Voigt LF, Weiss NS, Chu J. Daling JR. McKnight B, van Belle G. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet. 1991;338:274-277.
4. Stampfer MJ, Colditz GA. Estrogen replacement and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20: 47-63.
5. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016-1037.
6. Psaty BM, Heckbert SR, Atkins D, et al. A review of the association of estrogens and progestins with cardiovascular disease in post-menopausal women. Arch Intern Med. 1993;153:1421-1427.
7. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy, II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol. 1979;54:74-79.
8. Falkeborn M, Persson I, Adami HO, et al. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynecol. 1992;99:821-828.
9. Rosenberg L, Palmer JR, Shapiro S. A case-control study of myocardial infarction in relation to use of estrogen supplements. Am J Epidemiol. 1993; 137:54-63.
10. Hirvonen E, Malkonen M, Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med. 1981; 304:560-563.
11. Lobo RA. Effects of hormonal replacement on lipids and lipoproteins in post-menopausal women. J Clin Endocrinol Metab. 1991;73:925-930.
12. Henderson BE, Pike MC, Ross RK, Mack TM, Lobo RA. Re-evaluating the role of progestogen therapy after the menopause. Fertil Steril. 1988;49(suppl):9S-15S.
13. Psaty BM, Koepsell TD, LoGerfo JP, Wagner EH, Inui TS. Beta-blockers and primary prevention of coronary heart disease in patients with high blood pressure. JAMA. 1989;261:2087-2094.
14. Psaty BM, Koepsell TD, Siscovick D, et al. An approach to several problems in the use of large databases for population-based case-control studies of the therapeutic efficacy and safety of anti-hypertensive medicines. Stat Med. 1991; 10:653-662.
15. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263-276.
16. Schlesselman JJ. Case-Control Studies: Design, Conduct Analysis. New York, NY: Oxford University Press; 1982.
17. Breslow NE, Day NE. Statistical Methods in Cancer Research, Volume 1: The Analysis of Case-Control Studies. Lyon, France: International Agency for Research on Cancer; 1980. IARC scientific publication 32.
18. Norusis MJ. SPSS/PC+ 4.0 Bass Manual for the IBM PC/XT/AT and PS/2. Chicago, III: SPSS Inc; 1990.
19. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102-1109.
20. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991;325:1196-1204.
21. Thompson SG, Meade TW, Greenberg G. The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women. J Epidemiol Community Health. 1989;43:173-178.
22. Barrett Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med. 1991;115:455-456.